Uni Eropa -
Norwegia -
EMA (European Medicines Agency)
beyfortus
astrazeneca ab - nirsevimab - immune sera og immunglobuliner, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
Norwegia -
Norwegia -
Statens legemiddelverk
crestor 10 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg
Norwegia -
Norwegia -
Statens legemiddelverk
crestor 5 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg
Norwegia -
Norwegia -
Statens legemiddelverk
crestor 20 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg
Norwegia -
Norwegia -
Statens legemiddelverk
crestor 40 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg
Norwegia -
Norwegia -
Statens legemiddelverk
nexium 40 mg
grünenthal gmbh (1) - esomeprazolmagnesiumtrihydrat - enterotablett - 40 mg
Norwegia -
Norwegia -
Statens legemiddelverk
nexium 10 mg
grünenthal gmbh (1) - esomeprazolmagnesiumtrihydrat - enterogranulat til mikstur, suspensjon i dosepose - 10 mg
Norwegia -
Norwegia -
Statens legemiddelverk
nexium 20 mg
grünenthal gmbh (1) - esomeprazolmagnesiumtrihydrat - enterotablett - 20 mg
Norwegia -
Norwegia -
Statens legemiddelverk
nexium 40 mg
grünenthal gmbh (1) - esomeprazolnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 40 mg
Norwegia -
Norwegia -
Statens legemiddelverk
seroquel 100 mg
cheplapharm arzneimittel gmbh - kvetiapinfumarat - tablett, filmdrasjert - 100 mg